TrialBrain, behavior, and immunity2013

Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.

Divya Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.